Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
316
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extraintestinal Manifestations of Inflammatory Bowel Disease: A Focus on Kidney Complications.

International journal of molecular sciences·2026
Same author

Serum iron is associated with the prognosis in sepsis based on a large-scale database.

BMC infectious diseases·2026
Same author

Rodent Models for Atherosclerosis.

International journal of molecular sciences·2026
Same author

IDIC-Based Phototheranostic Nanoparticles for NIR Light-Excited Immuno-Phototherapy.

Luminescence : the journal of biological and chemical luminescence·2025
Same author

Rhabdomyolysis Induced by Irbesartan-Hydrochlorothiazide in an Elderly Patient.

Clinical case reports·2025
Same author

The Role of <i>ADIPOQ</i> and AMPK Signaling Pathway in Sarcopenia.

International journal of general medicine·2025

Related Experiment Video

Updated: Jun 17, 2025

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.5K

A Machine Learning Method for Differentiation Crohn's Disease and Intestinal Tuberculosis.

Yufeng Shu1, Zhe Chen2, Jingshu Chi1

  • 1Department of Gastroenterology, Third Xiangya Hospital, Central South University., Changsha, Hunan, People's Republic of China.

Journal of Multidisciplinary Healthcare
|August 13, 2024
PubMed
Summary

Machine learning (ML) effectively differentiates Crohn's disease (CD) and intestinal tuberculosis (ITB). An XGBoost model achieved high accuracy in clinical practice, showing strong agreement with multidisciplinary teams.

Keywords:
artificial intelligencecrohn’s diseaseintestinal tuberculosismachine learningmultidisciplinary team

More Related Videos

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.5K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.4K

Related Experiment Videos

Last Updated: Jun 17, 2025

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.5K
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.5K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.4K

Area of Science:

  • Medical Informatics
  • Machine Learning in Medicine
  • Diagnostic Accuracy

Background:

  • Differentiating Crohn's disease (CD) and intestinal tuberculosis (ITB) is clinically challenging.
  • Machine learning (ML) has potential for aiding in complex diagnoses.
  • The diagnostic utility of ML for CD and ITB requires investigation.

Purpose of the Study:

  • To evaluate the efficacy of ML models in distinguishing between CD and ITB.
  • To compare ML model performance against traditional diagnostic methods.
  • To identify key clinical features influencing ML-based differential diagnoses.

Main Methods:

  • Collected clinical data from 241 patients with 51 parameters.
  • Tested six ML algorithms: logistic regression, decision tree, k-nearest neighbor, multinomial NB, multilayer perceptron, and XGBoost.
  • Utilized SHAP and LIME for model interpretability and validated performance in clinical practice against a multidisciplinary team (MDT).

Main Results:

  • XGBoost demonstrated superior performance with an AUROC of 0.946 and accuracy of 0.884.
  • Key predictors included T-spot, pulmonary tuberculosis, and age of onset.
  • In clinical practice, the ML model achieved 0.860 accuracy, 0.833 sensitivity, and 0.871 specificity, with 90.7% agreement with MDT.

Conclusions:

  • An ML model, particularly XGBoost, can effectively and efficiently aid in the differential diagnosis of ITB and CD.
  • The developed ML model shows strong agreement with expert multidisciplinary team assessments.
  • The model's performance in real-world clinical settings supports its utility for improving diagnostic accuracy.